Literature DB >> 14689588

Fingerprinting the diseased prostate: associations between BPH and prostate cancer.

Uzma S Shah1, Robert H Getzenberg.   

Abstract

Two of the most common diseases which occur in ageing men relate to their prostate. BPH and prostate cancer are prevalent diseases which have an impact on most men as they age. The advent of gene expression analysis has provided an opportunity to examine these diseases in a novel fashion. These analyses, to date, have revealed associations between these two diseases which have not been previously identified. These commonalities include global genetic changes which occur throughout the prostates in individuals with these diseases. Understanding the fingerprints of these diseases is providing novel markers and treatment strategies for both BPH and prostate cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14689588     DOI: 10.1002/jcb.10739

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.

Authors:  Jeannette M Schenk; Alan R Kristal; Kathryn B Arnold; Catherine M Tangen; Marian L Neuhouser; Daniel W Lin; Emily White; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2011-05-03       Impact factor: 4.897

2.  Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.

Authors:  Xi Chen; Junjie Ma; Chengdang Xu; Licheng Wang; Yicong Yao; Xinan Wang; Tong Zi; Cuidong Bian; Denglong Wu; Gang Wu
Journal:  Discov Oncol       Date:  2022-06-30

3.  NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.

Authors:  Maria Papaioannou; Sonja Schleich; Daniela Roell; Undine Schubert; Tamzin Tanner; Frank Claessens; Rudolf Matusch; Aria Baniahmad
Journal:  Invest New Drugs       Date:  2009-09-23       Impact factor: 3.850

4.  Joint effects of inflammation and androgen metabolism on prostate cancer severity.

Authors:  Timothy R Rebbeck; Hanna Rennert; Amy H Walker; Saarene Panossian; Teo Tran; Kyle Walker; Elaine Spangler; Margerie Patacsil-Coomes; Rajeev Sachdeva; Alan J Wein; S Bruce Malkowicz; Charnita Zeigler-Johnson
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

5.  Novel methods to identify biologically relevant genes for leukemia and prostate cancer from gene expression profiles.

Authors:  Austin H Chen; Yin-Wu Tsau; Ching-Heng Lin
Journal:  BMC Genomics       Date:  2010-04-30       Impact factor: 3.969

6.  Screening key genes for abdominal aortic aneurysm based on gene expression omnibus dataset.

Authors:  Li Wan; Jingyong Huang; Haizhen Ni; Guanfeng Yu
Journal:  BMC Cardiovasc Disord       Date:  2018-02-13       Impact factor: 2.298

7.  Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.

Authors:  Ritsuko Nakamura; Takeru Oyama; Ryosuke Tajiri; Atsushi Mizokami; Mikio Namiki; Masaru Nakamoto; Akishi Ooi
Journal:  Cancer Sci       Date:  2015-03-26       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.